LoadingLoadingLoadingThe quick read
Latest quote·Oct 16
No insider open-market trades in 90 days (SEC Form 4). Congress: net selling of $16K to $65K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. Corteva Inc (CTVA) insiders filed no open-market purchases or sales in the 90 days to Oct 18, 2026, according to SEC Form 4 filings.
Rep. Gilbert Cisneros (D) sold $1K to $15K on Sep 17, 2026, disclosed 25 days later. Sen. Gary C Peters (D) sold $15K to $50K on Apr 23, 2026, disclosed 18 days later. In total, 2 members disclosed 2 CTVA trades with trade dates in the last 180 days, filed a median 22 days after trading.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position.
Buys/Adds (3)
Balyasny
$152.0M
added
Millennium
$61.8M
added
Citadel
$57.7M
added
Sells (2)
No tracked top-trader positions in CTVA right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 30, 2026
Financial period
Q2 2026
Earnings per share
$2.24 expected
Revenue
No comparable estimate
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $2.30 / $2.24Alpha Vantage | +2.68% beat | $6.38B / Unavailable | Unavailable |
| Mar 31, 2026 | May 5, 2026 | $1.50 / $1.18Alpha Vantage | +27.12% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 3, 2026 | $0.22 / $0.22Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 4, 2025 | -$0.23 / -$0.47Alpha Vantage | +51.06% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 6, 2025 | $2.20 / $1.88Alpha Vantage | +17.02% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 7, 2025 | $1.13 / $0.88Alpha Vantage | +28.41% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 5, 2025 | $0.32 / $0.31Alpha Vantage | +3.23% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 6, 2024 | -$0.49 / -$0.30Alpha Vantage | -63.33% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 17, 2026
EPS expected
$0.00 to $0.18
Revenue expected
3 analysts
Estimate drift
Change in 30 days
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.46B | $2.62B | $3.91B | $4.91B |
| Cost of what it sold | $2.93B | $1.64B | $2.25B | $2.37B |
| Gross profit | $3.52B | $974.0M | $1.66B | $2.53B |
| What it spent | ||||
| Research and development | $375.0M | $351.0M | $413.0M | $341.0M |
| Sales and admin | $1.16B | $731.0M | $842.0M | $877.0M |
| Other operating costs | $161.0M | $162.0M | $159.0M | $160.0M |
| Total operating expenses | $1.69B | $1.24B | $1.41B | $1.38B |
| What was left | ||||
| Operating profit | $1.83B | -$270.0M | $242.0M | $1.16B |
| Interest on debt | $52.0M | $46.0M | $46.0M | $36.0M |
| Profit before tax | $1.80B | -$370.0M | -$530.0M | $858.0M |
| Tax | $422.0M | -$62.0M | $7.0M | $133.0M |
| Net profit | $1.31B | -$320.0M | -$552.0M | $720.0M |
| EBITDA | $2.16B | -$24.0M | -$178.0M | $1.19B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
